Avatar Medical’s software platform for processing CT and MR images into three-dimensional (3D) anatomical models has obtained US Food and Drug Administration (FDA) clearance.
Known as Avatar Medical Vision, the software converts CT and MR imaging data into spatial, multi-dimensional representations that can be viewed across standard operating room displays, glasses-free 3D systems, and virtual reality (VR) environments.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Applicable for imaging across procedural modalities such as neurosurgery and interventional radiology, Avatar explained that the software gives physicians the ability to move beyond ‘flat’ interpretations of 3D image interpretation towards working directly with patient-specific anatomy in 3D.
FDA clearance for Avatar’s software establishes its compatibility with Eonis Vision, an autostereoscopic, ‘glasses-free’ screen for displaying medical images that Avatar developed alongside technology company Barco. Eonis Vision was launched in November 2025.
Avatar Medical’s CEO, Xavier Wartelle, said: “For too long, physicians have been making three-dimensional decisions from two-dimensional images.
“We’ve made deliberate technology choices to change that, prioritising glasses-free, shared visualisation so physicians and patients can look at anatomy together.”
Avatar’s software is intended to advance image visualisation in the operating room in a comparable manner to augmented and virtual reality (AR/VR) headsets. In healthcare, these technologies are gradually gaining particular traction in spine surgery. GlobalData analysts highlight that applying the technologies for advanced image visualisation holds the potential to enhance surgical planning, provide better intraoperative guidance, and ultimately improve patient care by increasing understanding of anatomy and surgical pathology.
The future potential of technologies such as 3D imaging, AR, and VR in the operating room, however, is currently hard to determine, as they remain in the early stages of development. In November 2025, Snke, which spun out of German imaging company Brainlab in June 2025, unveiled SnakeXR, which it claims is the first ‘medical grade’ AR headset.
Despite the future of 3D imaging in the healthcare space being difficult to predict, experts previously in conversation with Medical Device Network anticipate that in future, 3D imaging will have a key role to play in surgical planning and execution. While viewing anatomy across three axes is considered better for clinical outcomes, many 2D cross-sectional imaging systems still retain higher resolution.
